Home > Income Statement > TRIDENT LIFELINE

TRIDENT LIFELINE
Revenue

    Back to Income Statement
TRIDENT LIFELINE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

TRIDENT LIFELINE Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
Net Sales ₹87 Cr₹45 Cr₹32 Cr₹22 Cr

What is the latest Revenue of TRIDENT LIFELINE ?

The latest Revenue ratio of TRIDENT LIFELINE is ₹87 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹87 Cr
Mar2024₹45 Cr
Mar2023₹32 Cr
Mar2022₹22 Cr

How is Revenue of TRIDENT LIFELINE Trending?

Years Revenue % Change
Mar2025 ₹87 Cr
94.86
Mar2024 ₹45 Cr
40.82
Mar2023 ₹32 Cr
45.59
Mar2022 ₹22 Cr -

Compare Revenue of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹308.0 Cr 5.5% -1.5% -13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

5.5%

-1.5%

-13.6%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses